Lifileucel (Amtagvi) is an approved tumor-infiltrating lymphocyte (TIL) therapy for patients with advanced melanoma, but there are limited data on treatment of patients with brain ...

Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

NCCN now cites a molecular CP-GEP assay for SLNB risk stratification outside clinical trials in early-stage melanoma, representing a notable shift from prior guidance discouraging routine GEP use.

DEAR DR. ROACH: I was recently diagnosed with superficial spreading melanoma. I had a wide excision and was told to follow up with a dermatologist. The dermatologist says to follow up every six months ...

Dear Dr. Roach: I was recently diagnosed with superficial spreading melanoma. I had a wide excision and was told to follow up with a dermatologist. The dermatologist says to follow up every six months ...

A LARGE nationwide study from the Netherlands has provided new insight into how lentigo maligna (LM) is diagnosed and treated in routine clinical practice, revealing substantial rates of tumour ...

We used a database of patients who followed up with malignant melanoma at the university department (Department of Dermatovenereology, University Hospital, Pilsen, Czech Republic) to find a cohort of ...

Surgery is usually the main treatment for most types and stages of melanoma. If your tumor is in an early stage and removed using a melanoma surgical treatment, you may not need any other treatment.

Stage 2 melanoma involves a significant tumor without lymph node or distant organ spread, determined by tumor thickness and ulceration. Treatment focuses on curative surgical excision, with adjuvant ...

In a retrospective cohort of patients with melanoma in situ (MIS) with non-lentigo maligna/non-acral lentiginous (non-LM/non-ALM) subtypes, no local recurrences, metastases, or melanoma-specific ...

A phase 1/2 study of vusolimogene oderparepvec (RP1) in primary melanoma (mel) to reduce the risk of sentinel lymph node (SLN) metastasis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...